报告92例重症肌无力病者109次TEEM和抗AchR抗体的配对检测结果,发现延髓肌、脊髓肌型患者两种检测异常者均较高,眼肌型和全身肌无力型患者无显著差异。30岁以下发病者的细胞免疫异常显著高于30岁后发病者,抗AchR抗体的阳性检出率与年龄无明显相关。认为重症肌无力的免疫治疗应视发病年龄而別,30岁以下的女性患者应抑制细胞免疫反应,30岁以后者应以抑制体液免疫的方法为首选。 Report of 92 cases of myasthenia gravis 109 TEEM and anti-AchR antibody paired test results showed that the bulbar and spinal muscular patients were higher in both detection abnormalities, ocular muscle and generalized patients with no significant difference. The incidence of cellular immunity in patients under 30 years of age was significantly higher than that of those aged 30 years after onset. The positive detection rate of anti-AchR antibody was not significantly related to age. Immune treatment of myasthenia gravis should be considered as the age of onset and do not, under the age of 30 female patients should suppress the cellular immune response, after 30 years of age should be to suppress humoral immunity as the first choice.